X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (92) 92
infectious diseases (77) 77
male (73) 73
female (71) 71
adult (66) 66
hiv infections - drug therapy (60) 60
hiv (57) 57
index medicus (51) 51
thailand (42) 42
middle aged (41) 41
tuberculosis (34) 34
anti-hiv agents - therapeutic use (31) 31
drug therapy (31) 31
hiv infection (31) 31
antiretroviral therapy (28) 28
cd4 lymphocyte count (27) 27
virology (27) 27
hiv infections - complications (26) 26
treatment outcome (26) 26
immunology (24) 24
nevirapine (24) 24
risk factors (23) 23
human immunodeficiency virus--hiv (21) 21
research (20) 20
retrospective studies (20) 20
aids (19) 19
hiv infections - virology (18) 18
antiretroviral drugs (17) 17
antiviral agents (17) 17
efavirenz (17) 17
health aspects (17) 17
microbiology (17) 17
prospective studies (17) 17
tuberculosis - drug therapy (17) 17
cohort studies (16) 16
drug therapy, combination (16) 16
nevirapine - therapeutic use (16) 16
drug resistance (15) 15
hiv patients (15) 15
mortality (15) 15
public, environmental & occupational health (15) 15
thailand - epidemiology (15) 15
dosage and administration (14) 14
highly active antiretroviral therapy (14) 14
viral load (14) 14
aids/hiv (13) 13
patient outcomes (13) 13
reverse transcriptase inhibitors - therapeutic use (13) 13
young adult (13) 13
adolescent (12) 12
adults (12) 12
aged (12) 12
anti-hiv agents - adverse effects (12) 12
benzoxazines - therapeutic use (12) 12
efficacy (12) 12
hiv infections - immunology (12) 12
rifampin - therapeutic use (12) 12
safety (12) 12
therapy (12) 12
tuberculosis - complications (12) 12
anti-hiv agents - administration & dosage (11) 11
care and treatment (11) 11
hiv-1 (11) 11
hiv-1 - genetics (11) 11
infectious disease (11) 11
lamivudine - therapeutic use (11) 11
pharmacology & pharmacy (11) 11
tropical medicine (11) 11
antiretroviral therapy, highly active (10) 10
antitubercular agents - therapeutic use (10) 10
hiv infections - epidemiology (10) 10
tenofovir (10) 10
virus diseases (10) 10
genotype (9) 9
hiv-1 - drug effects (9) 9
infection (9) 9
lamivudine (9) 9
nevirapine - administration & dosage (9) 9
patients (9) 9
prevalence (9) 9
public health (9) 9
regimens (9) 9
resistance (9) 9
risk-factors (9) 9
survival (9) 9
antifungal agents - therapeutic use (8) 8
hiv-infected patients (8) 8
individuals (8) 8
molecular medicine (8) 8
mutations (8) 8
nevirapine - adverse effects (8) 8
rifampin (8) 8
rna (8) 8
rna, viral - blood (8) 8
usage (8) 8
viruses (8) 8
adenine - analogs & derivatives (7) 7
anti-hiv agents - blood (7) 7
anti-retroviral agents - therapeutic use (7) 7
fluconazole - therapeutic use (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2017, Volume 64, p. S167
New emerging pathogens can quickly become a global health threat in this era. A number of Middle East respiratory syndrome (MERS) outbreaks have been linked to... 
Health care | Global health | Epidemics | Vigilance | Disease transmission | Hospitals | Severe acute respiratory syndrome | Accident prevention | Outbreaks | Control systems | Disease control | Public health
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 03/2018, Volume 68, pp. 61 - 68
Journal Article
SpringerPlus, ISSN 2193-1801, 12/2016, Volume 5, Issue 1, pp. 1 - 6
Data on the success rate of sitafloxacin treatment in acute complicated urinary tract infection and pyelonephritis are limited.To determine the success rate of... 
Science | Urinary tract infection | Treatment | Pyelonephritis | Science, general | Sitafloxacin
Journal Article
Japanese Journal of Infectious Diseases, ISSN 1344-6304, 2018, Volume 71, Issue 3, pp. 220 - 224
Long-term complications of protease inhibitor (PI) treatment includes increased cardiovascular risks due to dyslipidemia in patients infected with human... 
protease inhibitor | human immunodeficiency virus (HIV) | statin | dyslipidemia | ezetimibe
Journal Article
Southeast Asian Journal of Tropical Medicine & Public Health, ISSN 0125-1562, 05/2014, Volume 45, Issue 3, pp. 622 - 622
Data regarding risk factors for hospitalization among children with influenza B infection are limited. The researchers conducted a retrospective study of 184... 
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 1019 - 1024
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2009, Volume 48, Issue 12, pp. 1752 - 1759
Background. To our knowledge, to date, no prospective, randomized, clinical trial has compared standard doses of efavirenz-and nevirapine-based antiretroviral... 
HIV/AIDS | Medical treatment failures | Antiretrovirals | Tuberculosis | Infectious diseases | RNA | AIDS | Infections | HIV 1 | Arts | Virology | INDIVIDUALS | SURVIVAL | MORTALITY | INFECTIOUS DISEASES | TUBERCULOSIS | ADULTS | MICROBIOLOGY | EFAVIRENZ 600 MG/DAY | ANTIRETROVIRAL THERAPY | OUTCOMES | IMMUNOLOGY | NEVIRAPINE LEVELS | Prospective Studies | Humans | Middle Aged | Male | Nevirapine - therapeutic use | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Anti-HIV Agents - administration & dosage | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Benzoxazines - pharmacokinetics | HIV-1 - isolation & purification | Tuberculosis - drug therapy | Adult | Anti-HIV Agents - therapeutic use | Female | Rifampin - therapeutic use | Reverse Transcriptase Inhibitors - therapeutic use | Benzoxazines - administration & dosage | Treatment Outcome | CD4 Lymphocyte Count | Benzoxazines - therapeutic use | Antiretroviral Therapy, Highly Active | Anti-HIV Agents - pharmacokinetics | Plasma - chemistry | HIV Infections - complications | HIV Infections - drug therapy | Nevirapine - administration & dosage | Nevirapine - pharmacokinetics | Antiviral agents | Usage | Patient outcomes | Reverse transcriptase inhibitors | Dosage and administration | Comparative analysis | Drug therapy | Rifampin | Health aspects | HIV infection | Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 8/2011, Volume 53, Issue 4, pp. 341 - 348
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 12/2017, Volume 17, Issue 12, pp. 1255 - 1265
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2009, Volume 49, Issue 9, pp. 1453 - 1454
Journal Article
Journal Article
Japanese Journal of Infectious Diseases, ISSN 1344-6304, 2018
Long-term complication of protease inhibitors (PIs) includes increased cardiovascular risks in HIV-infected patients due to dyslipidemia. Ezetimibe reduces... 
HIV | ezetimibe | statins | protease inhibitors | dyslipidemia
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2017, Volume 64, p. S171
Background. Delayed diagnosis of tuberculosis (TB) and drug-resistant TB are major challenges of TB control in Thailand. This study assessed the practicality... 
Centrifugation | Staining | Immune reconstitution | Viruses | Infections | Drug resistance | Medical diagnosis | Disease control | Patients | Gene sequencing | Sensitivity | Tuberculosis | Human immunodeficiency virus--HIV | Sputum | RpoB protein | Smear | Clinical medicine | Diagnosis | Rifampin | Culture
Journal Article